Prospective randomized study of safety outcomes treated with edoxaban in patients with stable coronary artery disease and atrial fibrillatio
Not Applicable
Completed
- Conditions
- on-valvular atrial fibrillation
- Registration Number
- JPRN-UMIN000032030
- Lead Sponsor
- ihon university school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who are contraindicated for edoxaban 2)Patients who are contraindicated for clopidogrel 3)Patients who are going to undergo revascularization 4)Those who are going to undergo invasive surgery (excluding digestive endoscopy and biopsy) 5)Patients who have active tumors 6)Patients who have poorly-controlled hypertension (systolic blood pressure at hospital admission: 160 mmHg or more) 7)Patients judged as inappropriate for this study by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method